We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests

By HospiMedica International staff writers
Posted on 13 Feb 2023
Print article
Image: Plasmon-enhanced LFAs (p-LFAs) improve inexpensive, readily available rapid tests to desired levels of sensitivity (Photo courtesy of WUSTL)
Image: Plasmon-enhanced LFAs (p-LFAs) improve inexpensive, readily available rapid tests to desired levels of sensitivity (Photo courtesy of WUSTL)

A key challenge in the field of infectious disease diagnostics is to quickly find out if a patient has a bacterial infection and needs antibiotics or has a viral infection for which antibiotics are not effective. Despite significant advances made in infectious disease diagnostics, there is still a need for simple, rapid and sensitive tests that can provide quantitative information and can be employed in sophisticated laboratories or in the field. In their effort to overcome the limitations of point-of-care diagnostic tests, researchers have now developed ultrabright fluorescent nanolabels called plasmonic-fluors, which can be quickly integrated into the lateral flow assay (LFA), a common testing platform. Plasmon-enhanced LFAs (p-LFAs) improve inexpensive, readily available rapid tests to the levels of sensitivity required by physicians for confidence in test results without the need for lab-based confirmation.

The p-LFAs designed by the research team at Washington University in St. Louis (WUSTL, St. Louis, MO, USA) are 1,000 times more sensitive than conventional LFAs, which show results via a visual color and fluorescence signal on the strip. When analyzed using a fluorescence scanner, p-LFAs are also significantly faster than gold-standard lab tests and return results within just 20 minutes instead of several hours, with equal or improved sensitivity. The p-LFAs can detect and quantify concentrations of proteins, enabling them to detect bacterial and viral infections as well as markers of inflammation that indicate other diseases. The improved testing capability fulfills the present need for quick and reliable test results and also eliminates the risk of false negatives. After proving that p-LFAs can outperform standard lab tests in sensitivity, speed, convenience and cost for one disease, the researchers now plan to develop new applications for the technology, including identifying bacterial versus viral infections and making their diagnostic tool accessible to physicians across the world.

“Our p-LFAs can pick up even very small concentrations of antibodies and antigens, typical markers of infection, and give clinicians clear, quick results without the need for specialized equipment,” explained Srikanth Singamaneni, a professor of mechanical engineering and materials science at the McKelvey School of Engineering at WUSTL. “For quantitative testing beyond the initial screening, the same LFA strip can be scanned with a fluorescence reader, enabling rapid and ultrasensitive colorimetric and fluorometric detection of disease markers with only one test.”

“We expect to have p-LFAs commercially available in the next one to two years,” Singamaneni said. “Right now, we’re working on improving our portable scanner technology, which adds a more sensitive, fluorescent reading capability to the test strips in addition to the color change that can be seen with the naked eye. We think we can get that cost down to a point where it’s accessible to rural clinics in the U.S. and abroad, which was one of our original goals.”

“We’re also excited about the potential to detect many more diseases than COVID, possibly using a skin patch that can take a painless sample,” Singamaneni added. “This technology has the potential to detect any number of diseases, ranging from STIs to respiratory infections and more, as well as cytokines indicative of inflammation seen in conditions such as rheumatoid arthritis and sepsis.”

Related Links:
WUSTL

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.